199 related articles for article (PubMed ID: 15042644)
41. Viral and clinical factors associated with surface gene variants among hepatitis B virus carriers.
Roque-Afonso AM; Férey MP; Ly TD; Graube A; Costa-Faria L; Samuel D; Dussaix E
Antivir Ther; 2007; 12(8):1255-63. PubMed ID: 18240865
[TBL] [Abstract][Full Text] [Related]
42. Transmission of "a" determinant variants of hepatitis B virus in immunized babies born to HBsAg carrier mothers.
Velu V; Saravanan S; Nandakumar S; Dhevahi E; Shankar EM; Murugavel KG; Kumarasamy T; Thyagarajan SP
Jpn J Infect Dis; 2008 Jan; 61(1):73-6. PubMed ID: 18219140
[TBL] [Abstract][Full Text] [Related]
43. Hepatitis B virus genetic diversity in Argentina: dissimilar genotype distribution in two different geographical regions; description of hepatitis B surface antigen variants.
Piñeiro Y Leone FG; Pezzano SC; Torres C; Rodríguez CE; Eugenia Garay M; Fainboim HA; Remondegui C; Sorrentino AP; Mbayed VA; Campos RH
J Clin Virol; 2008 Aug; 42(4):381-8. PubMed ID: 18479961
[TBL] [Abstract][Full Text] [Related]
44. Anti-hepatits B core antigen testing, viral markers, and occult hepatitis B virus infection in Pakistani blood donors: implications for transfusion practice.
Bhatti FA; Ullah Z; Salamat N; Ayub M; Ghani E
Transfusion; 2007 Jan; 47(1):74-9. PubMed ID: 17207233
[TBL] [Abstract][Full Text] [Related]
45. [Investigation of hemodialysis patients in terms of the presence of occult hepatitis B].
Altindiş M; Uslan I; Cetinkaya Z; Yüksel S; Ciftçi IH; Demirtürk N; Ozdemir M; Arslan F; Aktepe OC
Mikrobiyol Bul; 2007 Apr; 41(2):227-33. PubMed ID: 17682709
[TBL] [Abstract][Full Text] [Related]
46. Prevalence and risk factors of HBsAg in Gaza: implications for prevention and control.
Yassin K; Awad R; Tebi AJ; Queder A; Laaser U
J Infect; 2002 May; 44(4):252-6. PubMed ID: 12099733
[TBL] [Abstract][Full Text] [Related]
47. Hepatitis B virus genetic diversity and its impact on diagnostic assays.
Hollinger FB
J Viral Hepat; 2007 Nov; 14 Suppl 1():11-5. PubMed ID: 17958637
[TBL] [Abstract][Full Text] [Related]
48. Characteristics of hepatitis B virus in Ghana: full length genome sequences indicate the endemicity of genotype E in West Africa.
Huy TT; Ishikawa K; Ampofo W; Izumi T; Nakajima A; Ansah J; Tetteh JO; Nii-Trebi N; Aidoo S; Ofori-Adjei D; Sata T; Ushijima H; Abe K
J Med Virol; 2006 Feb; 78(2):178-84. PubMed ID: 16372296
[TBL] [Abstract][Full Text] [Related]
49. Hepatitis B virus genotyping, core promoter, and precore/core mutations among Afghan patients infected with hepatitis B: a preliminary report.
Amini-Bavil-Olyaee S; Alavian SM; Adeli A; Sarrami-Forooshani R; Sabahi F; Sabouri E; Tavangar HR; Azizi M; Mahboudi F
J Med Virol; 2006 Mar; 78(3):358-64. PubMed ID: 16419114
[TBL] [Abstract][Full Text] [Related]
50. Subgenotypes of hepatitis B virus genotype D (D1, D2, D3 and D5) in India: differential pattern of mutations, liver injury and occult HBV infection.
Chandra PK; Biswas A; Datta S; Banerjee A; Panigrahi R; Chakrabarti S; De BK; Chakravarty R
J Viral Hepat; 2009 Oct; 16(10):749-56. PubMed ID: 19457142
[TBL] [Abstract][Full Text] [Related]
51. Low levels of awareness, vaccine coverage, and the need for boosters among health care workers in tertiary care hospitals in India.
Sukriti ; Pati NT; Sethi A; Agrawal K; Agrawal K; Kumar GT; Kumar M; Kaanan AT; Sarin SK
J Gastroenterol Hepatol; 2008 Nov; 23(11):1710-5. PubMed ID: 18761556
[TBL] [Abstract][Full Text] [Related]
52. Epidemiology of hepatitis B in Canadian blood donors.
O'Brien SF; Xi G; Fan W; Yi QL; Fearon MA; Scalia V; Goldman M
Transfusion; 2008 Nov; 48(11):2323-30. PubMed ID: 18647366
[TBL] [Abstract][Full Text] [Related]
53. Performance of an algorithm for the reentry of volunteer blood donors deferred due to false-positive test results for antibody to hepatitis B core antigen.
Katz L; Strong DM; Tegtmeier G; Stramer S
Transfusion; 2008 Nov; 48(11):2315-22. PubMed ID: 18647367
[TBL] [Abstract][Full Text] [Related]
54. High prevalence of hepatitis B, C and delta virus infections among blood donors in Mongolia.
Tsatsralt-Od B; Takahashi M; Nishizawa T; Inoue J; Ulaankhuu D; Okamoto H
Arch Virol; 2005 Dec; 150(12):2513-28. PubMed ID: 16012782
[TBL] [Abstract][Full Text] [Related]
55. Genotyping of acute HBV isolates from England, 1997-2001.
Sloan RD; Strang AL; Ramsay ME; Teo CG
J Clin Virol; 2009 Feb; 44(2):157-60. PubMed ID: 19131271
[TBL] [Abstract][Full Text] [Related]
56. African links and hepatitis B virus genotypes in the Republic of Yemen.
Sallam TA; William Tong CY
J Med Virol; 2004 May; 73(1):23-8. PubMed ID: 15042643
[TBL] [Abstract][Full Text] [Related]
57. Two decades of hepatitis B infections among drug users in Amsterdam: are they still a high-risk group?
van Houdt R; van den Berg CH; Stolte IG; Bruisten SM; Dukers NH; Bakker M; Wolthers KC; Prins M; Coutinho RA
J Med Virol; 2009 Jul; 81(7):1163-9. PubMed ID: 19475623
[TBL] [Abstract][Full Text] [Related]
58. A new core promoter mutation and premature stop codon in the S gene in HBV strains from Iranian patients with cirrhosis.
Veazjalali M; Norder H; Magnius L; Jazayeri SM; Alavian SM; Mokhtari-Azad T
J Viral Hepat; 2009 Apr; 16(4):259-64. PubMed ID: 19222745
[TBL] [Abstract][Full Text] [Related]
59. A revised method for estimating hepatitis B virus transfusion residual risk based on antibody to hepatitis B core antigen incident cases.
Laperche S; Maniez M; Barlet V; El Ghouzzi MH; Le Vacon F; Levayer T; Lunel F; Morel P; Mouillot L; Piquet Y; Pillonel J;
Transfusion; 2008 Nov; 48(11):2308-14. PubMed ID: 18673347
[TBL] [Abstract][Full Text] [Related]
60. Hepatitis B virus DNA-positive, hepatitis B surface antigen-negative blood donations intercepted by anti-hepatitis B core antigen testing: the Canadian Blood Services experience.
O'Brien SF; Fearon MA; Yi QL; Fan W; Scalia V; Muntz IR; Vamvakas EC
Transfusion; 2007 Oct; 47(10):1809-15. PubMed ID: 17880605
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
